Question Everything!Everything!! |
Welcome to Truth, FREEDOM OR ANARCHY,Campaign of Conscience. , is an alternative media and news site that is dedicated to the truth, true journalism and the truth movement. The articles, ideas, quotes, books and movies are here to let everyone know the truth about our universe. The truth will set us free, it will enlighten, inspire, awaken and unite us. Armed with the truth united we stand, for peace, freedom, health and happiness for all
Question Everything!
This blog does not promote
This blog does not promote, support, condone, encourage, advocate, nor in any way endorse any racist (or "racialist") ideologies, nor any armed and/or violent revolutionary, seditionist and/or terrorist activities. Any racial separatist or militant groups listed here are solely for reference and Opinions of multiple authors including Freedom or Anarchy Campaign of conscience.
Saturday, January 10, 2015
Big Pharma Marijuana Drug Fails Clinical Studies
Big Pharma Marijuana Drug Fails Clinical Studies
With marijuana legalization on the horizon, many pharmaceutical companies are looking to take the natural herb, and turn it into one of their concoctions. Ironically, for British pharmaceutical company GW Pharmaceuticals their attempt at a marijuana drug has failed miserably in clinical trials, causing their stock to tumble by at least 21% this week.
The drug, called Sativex, was being designed as a pain relief medication. However, recent trials discovered that it showed little to no difference than a placebo when tested on patients.
“Although we missed the primary endpoint in this trial, based upon the positive data seen in the Phase II programme, we remain confident in the ability for Sativex to relieve cancer pain in this patient population,” GW Chief Executive Justin Gover said.http://news.yahoo.com/gw-pharmas-cannabis-drug-fails-cancer-pain-study-122308627--finance.html
Sativex is currently on the market already in 27 different countries, not as a pain reliever, but as an under-the-tongue spray used to treat multiple sclerosis.
Marijuana has a number of beneficial medical uses, however, it is very different than conventional mainstream medicine, so pharmaceutical companies may have a difficult time attempting to package this natural herb in the same way that they do their other products.
However, GW Pharmaceuticals does seem to be a bit more honest and positive than some of the competing corporations in the industry, but many marijuana advocates are still wary of pharmaceutical companies moving in on their favorite herb
In the video below, GW Pharmaceuticals CEO Justin Gover discusses his company’s history of making cannabinoid medications with Pimm Fox on Bloomberg Television’s “Taking Stock.”
by John Vibes
With marijuana legalization on the horizon, many pharmaceutical companies are looking to take the natural herb, and turn it into one of their concoctions. Ironically, for British pharmaceutical company GW Pharmaceuticals their attempt at a marijuana drug has failed miserably in clinical trials, causing their stock to tumble by at least 21% this week.
The drug, called Sativex, was being designed as a pain relief medication. However, recent trials discovered that it showed little to no difference than a placebo when tested on patients.
“Although we missed the primary endpoint in this trial, based upon the positive data seen in the Phase II programme, we remain confident in the ability for Sativex to relieve cancer pain in this patient population,” GW Chief Executive Justin Gover said.http://news.yahoo.com/gw-pharmas-cannabis-drug-fails-cancer-pain-study-122308627--finance.html
Sativex is currently on the market already in 27 different countries, not as a pain reliever, but as an under-the-tongue spray used to treat multiple sclerosis.
Marijuana has a number of beneficial medical uses, however, it is very different than conventional mainstream medicine, so pharmaceutical companies may have a difficult time attempting to package this natural herb in the same way that they do their other products.
However, GW Pharmaceuticals does seem to be a bit more honest and positive than some of the competing corporations in the industry, but many marijuana advocates are still wary of pharmaceutical companies moving in on their favorite herb
In the video below, GW Pharmaceuticals CEO Justin Gover discusses his company’s history of making cannabinoid medications with Pimm Fox on Bloomberg Television’s “Taking Stock.”
by John Vibes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Anyone is welcome to use their voice here at FREEDOM OR ANARCHY,Campaign of Conscience.THERE IS NO JUSTICE IN AMERICA FOR THOSE WITH OUT MONEY if you seek real change and the truth the first best way is to use the power of the human voice and unite the world in a common cause our own survival I believe that to meet the challenges of our times, human beings will have to develop a greater sense of universal responsibility. Each of us must learn to work not just for oneself, ones own family or ones nation, but for the benefit of all humankind. Universal responsibility is the key to human survival. It is the best foundation for world peace,“Never be afraid to raise your voice for honesty and truth and compassion against injustice and lying and greed. If people all over the world...would do this, it would change the earth.” Love and Peace to you all stand free and your ground feed another if you can let us the free call it LAWFUL REBELLION standing for what is right